Are you Dr. Doyle?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 37 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
22 S Greene St
Baltimore, MD 21201Phone+1 410-328-5793Fax+1 410-328-0248- Is this information wrong?
Summary
- Dr. Laurence Doyle, MD is an oncologist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland.
Education & Training
University of MarylandResidency, Internal Medicine, 1978 - 1981
University of Maryland School of MedicineClass of 1978
Certifications & Licensure
MD State Medical License 1979 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignancies.Joleen M. Hubbard, Jun Yin, Erin L. Schenk, Rui Qin, Joel M. Reid, Carrie Strand, Jack Fiskum, Michael Menefee, Grace Lin, L. Austin Doyle, Percy Ivy, Charles Erlichma...> ;Investigational New Drugs. 2021 Sep 13
- 40 citationsEffect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial.Kevin Kalinsky, Fangxin Hong, Carolyn K. McCourt, Jasgit C. Sachdev, Edith P. Mitchell, James A. Zwiebel, L. Austin Doyle, Lisa M. McShane, Shuli Li, Robert Gray, Larr...> ;JAMA Oncology. 2021 Feb 1
- 20 citationsA Phase I Study of Dinaciclib in Combination With MK-2206 in Patients With Advanced Pancreatic Cancer.Adrian Murphy, Marianna Zahurak, Mirat Shah, Colin D. Weekes, Aaron R. Hansen, Lillian L. Siu, Anna Spreafico, Noelle K. LoConte, Nicole M. Anders, Tearra Miles, Miche...> ;Clinical and Translational Science. 2020 Nov 1
- Join now to see all
